ArticleProbiotics and antimicrobial proteins2026
Biological Profiling of Postbiotics of Lactobacillus plantarum: Antibacterial, Antioxidant, and Cytotoxic Properties Under In Vitro and Food Circumstances.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The objective of this study was to analyze the chemical profile (gas chromatography-mass spectrometry), cell-based safety (cell viability, SOD and GSH-Px activity, NO production, and ROS activity), antioxidant properties (hydroxyl-, DPPH-radical scavenging activity, and linoleic acid peroxidation inhibitory activity), biofilm and auto-aggregation inhibitory activity, and antibacterial effects (minimum inhibitory concentration, minimum bactericidal concentration and minimum effective concentration) of Lactobacillus plantarum postbiotics (LPPs) in relation to Escherichia coli and Staphylococcus aureus. LPPs demonstrated notable Radical scavenging activity, with values of 72.30 ± 3.41% for hydroxyl RSA, 95.76 ± 3.72% for DPPH, and 20.98 ± 1.67% for linoleic acid peroxidation inhibition. Additionally, they demonstrated antibacterial effects against S. aureus (29.45 mm inhibition zone, minimum inhibitory concentration (MIC) of 32 µg/mL, minimum bactericidal concentration (MBC) of 50 µg/mL, minimal effective concentration (MEC) of 30 mg/mL for whole milk and 55 mg/mL for meat) and E. coli (21.17 mm inhibition zone, MIC 80 µg/mL, MBC 120 µg/mL, MEC 65 mg/mL milk, 85 mg/mL meat) with statistical significance noted (P < 0.05). LPPs demonstrated a positive effect on KDR cell viability, resulting in a significant enhancement of SOD and GSH-Px functions in these cells. Additionally, LPPs resulted in a decrease in NO production and a reduction in ROS levels (P < 0.05). Consequently, LPPs present a promising strategy for addressing the proliferation of S. aureus and E. coli, and they hold potential for application in the food industry to mitigate safety concerns associated with pathogenic microbes.
Indexed as
Identifiers
40965793What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.